Literature DB >> 15645014

The roles of aldo-keto reductases in steroid hormone action.

David R Bauman1, Stephan Steckelbroeck, Trevor M Penning.   

Abstract

The human aldo-keto reductase 1C (AKR1C) isozymes are implicated in the pre-receptor regulation of steroid receptors, nuclear orphan receptors and membrane-bound ligand-gated ion channels. Human AKR members that may regulate the local concentration of steroid hormones include: AKR1C1, AKR1C2, AKR1C3, AKR1C4 and AKR1D1. Since, these enzymes are pluripotent, the physiological role for the human AKR1C isozymes is determined by their tissue-specific expression patterns and their substrate availability in target tissues. AKRs work in concert with short-chain dehydrogenases/reductases as switches to control ligand access to nuclear receptors. Consequently, they are potential targets in treating prostate cancer, breast cancer, endometriosis and endometrial cancer. Copyright 2004 Prous Science. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15645014     DOI: 10.1358/dnp.2004.17.9.872570

Source DB:  PubMed          Journal:  Drug News Perspect        ISSN: 0214-0934


  21 in total

1.  Activities of aldo-keto reductase 1 enzymes on two inhaled corticosteroids: implications for the pharmacological effects of inhaled corticosteroids.

Authors:  Yi Jin
Journal:  Chem Biol Interact       Date:  2011-01-27       Impact factor: 5.192

Review 2.  Human hydroxysteroid dehydrogenases and pre-receptor regulation: insights into inhibitor design and evaluation.

Authors:  Trevor M Penning
Journal:  J Steroid Biochem Mol Biol       Date:  2011-01-25       Impact factor: 4.292

Review 3.  Androgens and doping tests: genetic variation and pit-falls.

Authors:  Anders Rane; Lena Ekström
Journal:  Br J Clin Pharmacol       Date:  2012-07       Impact factor: 4.335

4.  Fluorogenic metabolic probes for direct activity readout of redox enzymes: Selective measurement of human AKR1C2 in living cells.

Authors:  Dominic J Yee; Vojtech Balsanek; David R Bauman; Trevor M Penning; Dalibor Sames
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-28       Impact factor: 11.205

5.  Multiple steps determine the overall rate of the reduction of 5alpha-dihydrotestosterone catalyzed by human type 3 3alpha-hydroxysteroid dehydrogenase: implications for the elimination of androgens.

Authors:  Yi Jin; Trevor M Penning
Journal:  Biochemistry       Date:  2006-10-31       Impact factor: 3.162

6.  Anti-inflammatory drugs and uterine cervical cancer cells: Antineoplastic effect of meclofenamic acid.

Authors:  Alejandro D Soriano-Hernandez; Daniela Madrigal-Pérez; Hector R Galvan-Salazar; Margarita L Martinez-Fierro; Laura L Valdez-Velazquez; Francisco Espinoza-Gómez; Oscar F Vazquez-Vuelvas; Bertha A Olmedo-Buenrostro; Jose Guzman-Esquivel; Iram P Rodriguez-Sanchez; Agustin Lara-Esqueda; Daniel A Montes-Galindo; Ivan Delgado-Enciso
Journal:  Oncol Lett       Date:  2015-08-07       Impact factor: 2.967

7.  Cloning of a novel aldo-keto reductase gene from Klebsiella sp. strain F51-1-2 and its functional expression in Escherichia coli.

Authors:  Hong Jiang; Chao Yang; Hong Qu; Zheng Liu; Q S Fu; Chuanling Qiao
Journal:  Appl Environ Microbiol       Date:  2007-06-15       Impact factor: 4.792

8.  Role of microsomal retinol/sterol dehydrogenase-like short-chain dehydrogenases/reductases in the oxidation and epimerization of 3alpha-hydroxysteroids in human tissues.

Authors:  Olga V Belyaeva; Sergei V Chetyrkin; Amy L Clark; Natalia V Kostereva; Karen S SantaCruz; Bibie M Chronwall; Natalia Y Kedishvili
Journal:  Endocrinology       Date:  2007-02-08       Impact factor: 4.736

9.  Maternal and offspring genetic variants of AKR1C3 and the risk of childhood leukemia.

Authors:  Chen-yu Liu; Yi-Hsiang Hsu; Pi-Chen Pan; Ming-Tsang Wu; Chi-Kung Ho; Li Su; Xin Xu; Yi Li; David C Christiani
Journal:  Carcinogenesis       Date:  2008-03-13       Impact factor: 4.944

10.  Association between SNPs within candidate genes and compounds related to boar taint and reproduction.

Authors:  Maren Moe; Sigbjørn Lien; Torunn Aasmundstad; Theo H E Meuwissen; Marianne H S Hansen; Christian Bendixen; Eli Grindflek
Journal:  BMC Genet       Date:  2009-07-05       Impact factor: 2.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.